PH12013500991A1 - 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGLuR 2/3 ANTAGONISTS - Google Patents
4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGLuR 2/3 ANTAGONISTSInfo
- Publication number
- PH12013500991A1 PH12013500991A1 PH1/2013/500991A PH12013500991A PH12013500991A1 PH 12013500991 A1 PH12013500991 A1 PH 12013500991A1 PH 12013500991 A PH12013500991 A PH 12013500991A PH 12013500991 A1 PH12013500991 A1 PH 12013500991A1
- Authority
- PH
- Philippines
- Prior art keywords
- phenylsulfanylmethyl
- mglur
- bicyclo
- antagonists
- substituted
- Prior art date
Links
- -1 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS Chemical class 0.000 title 1
- 229940127592 mGluR2/3 antagonist Drugs 0.000 title 1
- 101001071429 Homo sapiens Metabotropic glutamate receptor 2 Proteins 0.000 abstract 1
- 102100036837 Metabotropic glutamate receptor 2 Human genes 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A mGlu2/3 receptor antagonist of the formula (I):, its uses, and methods for its preparation are described.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41512110P | 2010-11-18 | 2010-11-18 | |
| PCT/US2011/060730 WO2012068067A1 (en) | 2010-11-18 | 2011-11-15 | 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12013500991A1 true PH12013500991A1 (en) | 2015-02-11 |
Family
ID=45099188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2013/500991A PH12013500991A1 (en) | 2010-11-18 | 2011-11-15 | 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGLuR 2/3 ANTAGONISTS |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US8629169B2 (en) |
| EP (1) | EP2640697B1 (en) |
| JP (1) | JP5877847B2 (en) |
| KR (2) | KR20130101094A (en) |
| CN (1) | CN103228625B (en) |
| AR (1) | AR083845A1 (en) |
| AU (1) | AU2011329076B2 (en) |
| BR (1) | BR112013012118A2 (en) |
| CA (1) | CA2818116C (en) |
| CL (1) | CL2013001345A1 (en) |
| CO (1) | CO6761385A2 (en) |
| CR (1) | CR20130178A (en) |
| DK (1) | DK2640697T3 (en) |
| DO (1) | DOP2013000099A (en) |
| EA (1) | EA021724B1 (en) |
| EC (1) | ECSP13012629A (en) |
| ES (1) | ES2650139T3 (en) |
| GT (1) | GT201300126A (en) |
| HR (1) | HRP20171649T1 (en) |
| HU (1) | HUE037457T2 (en) |
| IL (1) | IL225843A (en) |
| LT (1) | LT2640697T (en) |
| MA (1) | MA34663B1 (en) |
| MX (1) | MX339973B (en) |
| NO (1) | NO2640697T3 (en) |
| NZ (1) | NZ609816A (en) |
| PE (1) | PE20140997A1 (en) |
| PH (1) | PH12013500991A1 (en) |
| PL (1) | PL2640697T3 (en) |
| PT (1) | PT2640697T (en) |
| RS (1) | RS56535B1 (en) |
| SG (1) | SG189959A1 (en) |
| SI (1) | SI2640697T1 (en) |
| TW (1) | TWI520935B (en) |
| UA (1) | UA110039C2 (en) |
| WO (1) | WO2012068067A1 (en) |
| ZA (1) | ZA201302918B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR079343A1 (en) * | 2009-12-21 | 2012-01-18 | Lilly Co Eli | ACID COMPOUND 2-AMINO-4- (4H-1,2,4-TRIAZOL-3-ILSULFANIL) BICYCLE [3.1.0] HEXANO-2,6-DICARBOXILICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT USEFUL TO TREAT A PSYCHIATRIC DISORDER |
| EP3000814A1 (en) | 2014-09-26 | 2016-03-30 | Domain Therapeutics | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors |
| AU2017254266B2 (en) | 2016-04-18 | 2021-03-11 | Taisho Pharmaceutical Co., Ltd. | Prodrug of amino acid derivative |
| EP3570832A4 (en) | 2017-01-17 | 2020-06-10 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
| US11046649B2 (en) | 2018-07-17 | 2021-06-29 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0669928B2 (en) | 1987-10-06 | 1994-09-07 | 宇部興産株式会社 | Photopolymerizable dental material |
| JP2589812B2 (en) | 1989-07-05 | 1997-03-12 | 松下電器産業株式会社 | Steam iron |
| JP2000500752A (en) | 1995-11-16 | 2000-01-25 | イーライ・リリー・アンド・カンパニー | Excitatory amino acid receptor antagonist |
| ZA969485B (en) | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| DE69919142T2 (en) * | 1998-03-17 | 2005-01-20 | Pfizer Products Inc., Groton | BICYCLO [2.2.1] HEPTANESE AND RELATED COMPOUNDS |
| GB9815542D0 (en) | 1998-07-17 | 1998-09-16 | Lilly Co Eli | Bicyclohexane derivatives |
| CH694053A5 (en) | 1998-09-03 | 2004-06-30 | Hoffmann La Roche | Ver method for the production of 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivatives. |
| EP1370519A1 (en) * | 2001-02-22 | 2003-12-17 | Eli Lilly And Company | Synthetic excitatory amino acids |
| RU2315622C2 (en) | 2001-12-27 | 2008-01-27 | Тайсо Фармасьютикал Ко.,Лтд. | Derivatives of 6-fluorobicyclo[3.1.0]hexane |
| HRP20090058A2 (en) | 2002-06-11 | 2009-04-30 | Eli Lilly And Company | Precursor Forms of Drugs for Amino Acids with Incentive Activity |
| JP2007063129A (en) | 2003-06-26 | 2007-03-15 | Taisho Pharmaceut Co Ltd | 2-Amino-3-alkoxybicyclo [3.1.0] hexane derivatives |
| US7381746B2 (en) * | 2003-06-26 | 2008-06-03 | Taisho Pharmaceutical Co., Ltd. | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| ATE487690T1 (en) * | 2003-06-26 | 2010-11-15 | Taisho Pharmaceutical Co Ltd | 2-AMINOBICYCLO 3.1.0 HEXANE-2,6-DICARBONIC ACID ESTER DERIVATIVE |
| AR079343A1 (en) * | 2009-12-21 | 2012-01-18 | Lilly Co Eli | ACID COMPOUND 2-AMINO-4- (4H-1,2,4-TRIAZOL-3-ILSULFANIL) BICYCLE [3.1.0] HEXANO-2,6-DICARBOXILICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT USEFUL TO TREAT A PSYCHIATRIC DISORDER |
-
2011
- 2011-11-11 AR ARP110104219A patent/AR083845A1/en unknown
- 2011-11-11 TW TW100141326A patent/TWI520935B/en not_active IP Right Cessation
- 2011-11-15 NZ NZ609816A patent/NZ609816A/en not_active IP Right Cessation
- 2011-11-15 JP JP2013539938A patent/JP5877847B2/en active Active
- 2011-11-15 SI SI201131304T patent/SI2640697T1/en unknown
- 2011-11-15 SG SG2013030507A patent/SG189959A1/en unknown
- 2011-11-15 KR KR1020137012697A patent/KR20130101094A/en not_active Abandoned
- 2011-11-15 PE PE2013001215A patent/PE20140997A1/en not_active Application Discontinuation
- 2011-11-15 DK DK11791692.4T patent/DK2640697T3/en active
- 2011-11-15 WO PCT/US2011/060730 patent/WO2012068067A1/en not_active Ceased
- 2011-11-15 CN CN201180055263.7A patent/CN103228625B/en active Active
- 2011-11-15 US US13/296,384 patent/US8629169B2/en active Active
- 2011-11-15 AU AU2011329076A patent/AU2011329076B2/en not_active Ceased
- 2011-11-15 KR KR1020157034547A patent/KR20150140876A/en not_active Ceased
- 2011-11-15 EP EP11791692.4A patent/EP2640697B1/en active Active
- 2011-11-15 EA EA201390498A patent/EA021724B1/en not_active IP Right Cessation
- 2011-11-15 NO NO11791692A patent/NO2640697T3/no unknown
- 2011-11-15 LT LTEP11791692.4T patent/LT2640697T/en unknown
- 2011-11-15 CA CA2818116A patent/CA2818116C/en active Active
- 2011-11-15 ES ES11791692.4T patent/ES2650139T3/en active Active
- 2011-11-15 MX MX2013005622A patent/MX339973B/en active IP Right Grant
- 2011-11-15 PT PT117916924T patent/PT2640697T/en unknown
- 2011-11-15 UA UAA201305835A patent/UA110039C2/en unknown
- 2011-11-15 PL PL11791692T patent/PL2640697T3/en unknown
- 2011-11-15 PH PH1/2013/500991A patent/PH12013500991A1/en unknown
- 2011-11-15 BR BR112013012118A patent/BR112013012118A2/en not_active IP Right Cessation
- 2011-11-15 HR HRP20171649TT patent/HRP20171649T1/en unknown
- 2011-11-15 HU HUE11791692A patent/HUE037457T2/en unknown
- 2011-11-15 RS RS20171082A patent/RS56535B1/en unknown
-
2013
- 2013-04-18 IL IL225843A patent/IL225843A/en not_active IP Right Cessation
- 2013-04-22 ZA ZA2013/02918A patent/ZA201302918B/en unknown
- 2013-04-24 CR CR20130178A patent/CR20130178A/en unknown
- 2013-05-08 DO DO2013000099A patent/DOP2013000099A/en unknown
- 2013-05-13 MA MA35898A patent/MA34663B1/en unknown
- 2013-05-15 CL CL2013001345A patent/CL2013001345A1/en unknown
- 2013-05-15 GT GT201300126A patent/GT201300126A/en unknown
- 2013-05-17 EC ECSP13012629 patent/ECSP13012629A/en unknown
- 2013-05-30 CO CO13133036A patent/CO6761385A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201017345D0 (en) | Receptor antagonists | |
| MY181898A (en) | Heterocyclic compounds and uses thereof | |
| GEP201706745B (en) | Forms of rifaximin and usage thereof | |
| MX2012007507A (en) | Heteroaryl compounds and uses thereof. | |
| EP4268814A3 (en) | Pharmaceutical composition for the treatment of dry eye | |
| MY160665A (en) | Spiropiperidine compounds as orl-1 receptor antagonists | |
| AP2012006630A0 (en) | Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor | |
| PH12013500991A1 (en) | 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGLuR 2/3 ANTAGONISTS | |
| MX2013005623A (en) | 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS. | |
| PH12013500210A1 (en) | Highly crystalline valsartan | |
| PH12012502300A1 (en) | Nicotinic receptor non-competitive antagonists | |
| WO2012139074A3 (en) | Migrastatins and uses thereof | |
| TN2013000209A1 (en) | 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists | |
| IL225763A0 (en) | Preparation of bicyclo[2.2.2]octan-2-one compounds | |
| HK40120913A (en) | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof | |
| WO2013067105A3 (en) | Nicotinic receptor non-competitive modulators | |
| MX2012013075A (en) | Novel methods for the preparation of p2x7r antagonists. | |
| UA54879U (en) | Use of antagonist of interleukin-1 receptor as antioxidant agent | |
| WO2012094437A3 (en) | Nicotinic receptor non-competitive antagonists | |
| UA108500C2 (en) | Noncompetitive antagonists of nicotinic receptors | |
| UA51902U (en) | use of interleukin-1 receptor antagonists (aryl-1) as frigoprotective agent | |
| UA40770U (en) | use of interleukine-1 receptor antagonist as cardioprotective agent | |
| PL392583A1 (en) | Process for the preparation of 2,3-di(metoxycarbonyl)-5-norbornene | |
| UA74358U (en) | Phytotea composition | |
| UA56041U (en) | 1,3-dimethyl-7-n-methylbenzene-8-n-hydrazinoxanthine exhibiting diuretic action |